Nomad Power Solutions (NMAD) Assets (2010 - 2026)
Nomad Power Solutions (NMAD) posted Assets of $26.6 million for Q2 2026, up 109.28% on a QoQ basis from $12.7 million in Q4 2025, and up 2142.08% year-over-year from $1.2 million in Q2 2025.
Analysis
Nomad Power Solutions (NMAD) Assets (2010 - 2026) Analysis & Trends
Nomad Power Solutions has reported Assets for 17 years, with the latest figure at $26.6 million in Q2 2026.
- On a quarterly basis, Assets rose 2142.08% year-over-year to $26.6 million in Q2 2026; TTM through Jun 2026 was $26.6 million, a 2142.08% increase from a year earlier, with the FY2025 full-year figure at $12.7 million, up 1011.62% from the prior year.
- Assets was $26.6 million for Q2 2026 at Nomad Power Solutions, up from $12.7 million in the prior quarter.
- The five-year high for Assets was $26.6 million in Q2 2026, with the low at $1.1 million in Q4 2024.
- Average Assets over 5 years is $5.8 million, with a median of $4.3 million recorded in 2023.
- The sharpest annual moves came in 2024 and 2026: Assets sank 73.41% in 2024, then surged 2142.08% in 2026.
- Over 5 years, Assets stood at $5.6 million in 2022, then dropped by 22.52% to $4.3 million in 2023, then tumbled by 73.41% to $1.1 million in 2024, then soared by 1011.62% to $12.7 million in 2025, then jumped by 109.28% to $26.6 million in 2026.
- The last three Assets figures came in at $26.6 million (Q2 2026), $12.7 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 95.64 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 49.36 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 27.42 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 41.73 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 10.03 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 10.96 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 5.56 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 32.09 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 5.31 Bn |
| 10 | Nomad Power Solutions | 49.59 Mn | 49.59 Mn | - | 26.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.65 Mn |
| Dec 31, 2025 | 12.73 Mn |
| Sep 30, 2025 | 5.43 Mn |
| Jun 30, 2025 | 1.19 Mn |
| Mar 31, 2025 | 1.51 Mn |
| Dec 31, 2024 | 1.15 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 2.67 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Dec 31, 2023 | 4.31 Mn |
| Sep 30, 2023 | 5.23 Mn |
| Jun 30, 2023 | 3.10 Mn |
| Mar 31, 2023 | 4.33 Mn |
| Dec 31, 2022 | 5.56 Mn |
| Sep 30, 2022 | 6.82 Mn |
| Jun 30, 2022 | 8.02 Mn |
| Mar 31, 2022 | 4.12 Mn |
| Dec 31, 2021 | 5.09 Mn |
| Sep 30, 2021 | 6.33 Mn |
| Jun 30, 2021 | 7.24 Mn |